カテゴリー： IMARC, 世界, 医療/バイオ

肺マーカーの世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測

◆英語タイトル：Lung Marker Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

IMARCが発行した調査報告書（IMARC23JLY146）◆商品コード：IMARC23JLY146
◆発行会社（リサーチ会社）：IMARC
◆発行日：2023年7月
◆ページ数：141
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single UserUSD2,999 ⇒換算￥449,850見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算￥599,850見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算￥749,850見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

アイマーク社の本市場調査資料によると、2022年に393.0百万ドルであった世界の肺マーカー市場規模が、2028年までに731.0百万ドルに達し、予測期間中（2023-2028）にCAGR 11.5%成長すると予想しています。本資料では、肺マーカーの世界市場について調査・分析し、序論、市場範囲・定義、エグゼクティブサマリー、イントロダクション、市場概況、がん種類別（非小細胞肺がん（NSCLC）、小細胞肺がん（SCLC））分析、マーカー種類別（EGFR、EML4-ALK、KRAS、BRAF、その他）分析、エンドユーザー別（病院、検査機関、その他）分析、地域別（北米、アメリカ、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、スペイン、ロシア、アジア太平洋、中国、日本、インド、韓国、オーストラリア、インドネシア、中南米、ブラジル、メキシコ、アルゼンチン、コロンビア、チリ、ペルー、中東・アフリカ、トルコ、イラン）分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格指標、競争状況などの内容をまとめています。なお、本資料には、Abbott Laboratories、Thermo Fisher Scientific Inc.、Agilent Technologies, Inc.、Beckman Coulter, Inc.、Fujirebio Europe N.V.、Hologic, Inc.、F. Hoffmann-La Roche Ltd、Siemens Healthineers、BioSpace, Inc.などの企業情報が含まれています。
・序論
・市場範囲・定義
・エグゼクティブサマリー
・イントロダクション
・市場概況
・世界の肺マーカー市場規模：がん種類別
- 非小細胞肺がん（NSCLC）の市場規模
- 小細胞肺がん（SCLC）の市場規模
・世界の肺マーカー市場規模：マーカー種類別
- EGFRの市場規模
- EML4-ALKの市場規模
- KRASの市場規模
- BRAFの市場規模
- その他マーカー種類の市場規模
・世界の肺マーカー市場規模：エンドユーザー別
- 病院における市場規模
- 検査機関における市場規模
- その他エンドユーザーにおける市場規模
・世界の肺マーカー市場規模：地域別
- 北米の肺マーカー市場規模
アメリカの肺マーカー市場規模
カナダの肺マーカー市場規模
- ヨーロッパの肺マーカー市場規模
ドイツの肺マーカー市場規模
フランスの肺マーカー市場規模
イギリスの肺マーカー市場規模
…
- アジア太平洋の肺マーカー市場規模
中国の肺マーカー市場規模
日本の肺マーカー市場規模
インドの肺マーカー市場規模
…
- 中南米の肺マーカー市場規模
ブラジルの肺マーカー市場規模
メキシコの肺マーカー市場規模
アルゼンチンの肺マーカー市場規模
チリの肺マーカー市場規模
ペルーの肺マーカー市場規模
…
- 中東・アフリカの肺マーカー市場規模
トルコの肺マーカー市場規模
イランの肺マーカー市場規模
…
・SWOT分析
・バリューチェーン分析
・ファイブフォース分析
・価格指標
・競争状況

Market Overview:

The global lung marker market size reached US$ 393.0 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 731.0 Million by 2028, exhibiting a growth rate (CAGR) of 11.5% during 2023-2028.

Generally, four major types of lung markers, including EGFR, EML4-ALK, KRAS, and BRAF, are used during lung intervention procedures or lung surgeries and diagnosis. Furthermore, the markers are used to detect, diagnose, predict, and monitor the tumor, based on which the treatment is prescribed to the patient. Lung markers are only used as an additional tool to identify cancer along with several imaging tests and biopsy. Owing to this, lung markers are extensively used in thoracoscopic surgeries across hospitals, ambulatory surgical clinics, and specialty clinics, among several other healthcare facilities.

The rising demand for lung markers can be attributed to the high prevalence of respiratory disorders, such as pleural effusion, pleural mesothelioma, pleural plaque, etc., due to the increasing air pollution levels, across the globe. Besides this, the high exposure to passive smoking, along with a family history of lung cancer further drives the number of patients suffering from lung cancer, thereby augmenting the demand for lung markers. Additionally, the surging geriatric population, along with the hectic consumer lifestyles leading to a high smoking rate, further accelerate the risks of several respiratory disorders. Apart from this, the increasing healthcare expenditures by various governments for early diagnosis and pre-treatment of life-threatening diseases, such as lung cancer, are also propelling the rising utilization of lung markers at a global level. Furthermore, rising investments in several research and development activities in the field of lung cancer diagnostics and treatment is further catalyzing the demand for lung markers. In addition to this, the increasing usage of lung markers in hospitals, surgery centers, clinics, and their various applications in therapeutic purposes has also catalyzed the product demand.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global lung marker market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on cancer type, marker type and end user.

Breakup by Cancer Type:
Non-Small Cell Lung Cancer (NSCLC)
Small Cell Lung Cancer (SCLC)

Breakup by Marker Type:
EGFR
EML4-ALK
KRAS
BRAF
Others

Breakup by End User:
Hospitals
Diagnostic Labs
Others

Breakup by Region:
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Argentina
Colombia
Chile
Peru
Others
Middle East and Africa
Turkey
Iran
Others

Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Beckman Coulter, Inc., Fujirebio Europe N.V., Hologic, Inc., F. Hoffmann-La Roche Ltd, Siemens Healthineers, and BioSpace, Inc.

Key Questions Answered in This Report:
How has the global lung marker market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global lung marker market?
What are the key regional markets?
What is the breakup of the market based on the cancer type?
What is the breakup of the market based on the marker type?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global lung marker market and who are the key players?
What is the degree of competition in the industry?

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Lung Marker Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact Of COVID-19
5.4 Market Forecast
6 Market Breakup by Cancer Type
6.1 Non-Small Cell Lung Cancer (NSCLC)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Small Cell Lung Cancer (SCLC)
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Marker Type
7.1 EGFR
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 EML4-ALK
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 KRAS
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 BRAF
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Diagnostic Labs
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Europe
9.2.1 Germany
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 France
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 United Kingdom
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 Italy
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Spain
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Russia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Asia Pacific
9.3.1 China
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 Japan
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 India
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 South Korea
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Australia
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Indonesia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Argentina
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.4.4 Colombia
9.4.4.1 Market Trends
9.4.4.2 Market Forecast
9.4.5 Chile
9.4.5.1 Market Trends
9.4.5.2 Market Forecast
9.4.6 Peru
9.4.6.1 Market Trends
9.4.6.2 Market Forecast
9.4.7 Others
9.4.7.1 Market Trends
9.4.7.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Turkey
9.5.1.1 Market Trends
9.5.1.2 Market Forecast
9.5.2 Iran
9.5.2.1 Market Trends
9.5.2.2 Market Forecast
9.5.3 Others
9.5.3.1 Market Trends
9.5.3.2 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Indicators
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Thermo Fisher Scientific Inc
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Agilent Technologies, Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Beckman Coulter, Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Fujirebio Europe N.V., Hologic, Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 F. Hoffmann-La Roche Ltd
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Siemens Healthineers
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 BioSpace, Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis

Figure 1: Global: Lung Marker Market: Major Drivers and Challenges
Figure 2: Global: Lung Marker Market: Sales Value (in Million US$), 2017-2022
Figure 3: Global: Lung Marker Market: Breakup by Cancer Type (in %), 2022
Figure 4: Global: Lung Marker Market: Breakup by Marker Type (in %), 2022
Figure 5: Global: Lung Marker Market: Breakup by End User (in %), 2022
Figure 6: Global: Lung Marker Market: Breakup by Region (in %), 2022
Figure 7: Global: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 8: Global: Lung Marker (NSCLC) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Lung Marker (NSCLC) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Lung Marker (SCLC) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Lung Marker (SCLC) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Lung Marker (EGFR) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Lung Marker (EGFR) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Lung Marker (EML4-ALK) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Lung Marker (EML4-ALK) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Lung Marker (KRAS) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Lung Marker (KRAS) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Lung Marker (BRAF) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Lung Marker (BRAF) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Lung Marker (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Lung Marker (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Lung Marker (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Lung Marker (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Lung Marker (Diagnostic Labs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Lung Marker (Diagnostic Labs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Lung Marker (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Lung Marker (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: North America: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: North America: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: United States: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: United States: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Canada: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Canada: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Asia Pacific: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Asia Pacific: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: China: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: China: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Japan: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Japan: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: India: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: India: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: South Korea: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: South Korea: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Australia: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Australia: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Indonesia: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Indonesia: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Others: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Others: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Europe: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Europe: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Germany: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Germany: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: France: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: France: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: United Kingdom: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: United Kingdom: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Italy: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Italy: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Spain: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Spain: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Russia: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Russia: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Others: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Others: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Middle East and Africa: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Middle East and Africa: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Turkey: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Turkey: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Iran: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Iran: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Others: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Others: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Latin America: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Latin America: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Brazil: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Brazil: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Mexico: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Mexico: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Argentina: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Argentina: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Colombia: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: Colombia: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Chile: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: Chile: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Peru: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 87: Peru: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 88: Others: Lung Marker Market: Sales Value (in Million US$), 2017 & 2022
Figure 89: Others: Lung Marker Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 90: Global: Lung Marker Industry: SWOT Analysis
Figure 91: Global: Lung Marker Industry: Value Chain Analysis
Figure 92: Global: Lung Marker Industry: Porter’s Five Forces Analysis

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 肺マーカーの世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測(Lung Marker Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028)]についてメールでお問い合わせはこちらでお願いします。
グローバルリサーチ調査資料のイメージグローバルリサーチ調査資料のイメージ
◆関連リサーチレポート◆
  • がん免疫療法の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • 腫瘍分子診断の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • 癌バイオマーカーの世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • がんワクチンの世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • 放射線腫瘍学の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測

    • ◆H&Iグローバルリサーチのお客様（例）◆